CVS Health Corp. buy Subdi
Summary
This prediction ended on 16.07.22 with a price of €95.19. With a performance of 99.31% the BUY prediction by Subdi was a big success. A total of €6.21 was paid as dividends for this prediction. Subdi has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CVS Health Corp. | -2.507% | -2.507% | 3.254% | -8.585% |
| iShares Core DAX® | -2,12 % | -8,18 % | -1,47 % | 54,14 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % | 19,96 % | 83,32 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % | 27,47 % | 53,61 % |
| iShares S&P 500 | -1,26 % | -1,00 % | 13,63 % | 62,62 % |
Comments by Subdi for this prediction
In the thread CVS Health Corp. diskutieren
Subdi stimmt der Buy-Einschätzung von tamam zu
Subdi stimmt am 09.03.2019 der Buy-Einschätzung von tamam mit dem Kursziel 85$ zu.
Überschrift: tamam stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu